Literature DB >> 23943822

Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus.

Liang Yu1, Zhaoming Wang, Yu Chen, Wei Ding, Hongyu Jia, Jasper Fuk-Woo Chan, Kelvin Kai-Wang To, Honglin Chen, Yida Yang, Weifeng Liang, Shufa Zheng, Hangping Yao, Shigui Yang, Hongcui Cao, Xiahong Dai, Hong Zhao, Ju Li, Qiongling Bao, Ping Chen, Xiaoli Hou, Lanjuan Li, Kwok-Yung Yuen.   

Abstract

BACKGROUND: Systematic analysis of histopathological and serial virological changes of fatal influenza A(H7N9) cases is lacking.
METHODS: Patients with A(H7N9) infection admitted to our intensive care unit during 10-23 April 2013 were included. Viral loads in the respiratory tract, as inferred from the cycle threshold (Ct) value of reverse transcription polymerase chain reaction (RT-PCR), and the serum hemagglutination inhibition (HAI) antibody titer, were analyzed. Postmortem biopsies of the lung, liver, kidney, spleen, bone marrow, and heart were examined.
RESULTS: Twelve patients (6 deaths, 6 survivors) were included. Median viral load was higher in sputa than the nasopharyngeal swabs for fatal cases (median Ct, 23 vs 30.5; P = .08). RT-PCR for A(H7N9) was positive in stool samples (4/6 [67%]) of fatal cases and (2/6 [33%]) of survivors, but was negative in the cerebrospinal fluid, urine, or blood of all patients. Nosocomial bacterial infections were more common in patients who died than in survivors (83% vs 50%). HAI titers increased by ≥4-fold in those with convalescent sera. Postmortem biopsy for 3 patients showed acute diffuse alveolar damage. Patient 1, who died 8 days after symptom onset, had intra-alveolar hemorrhage. Patients 2 and 3, who died 11 days after symptom onset, had pulmonary fibroproliferative changes. Reactive hemophagocytosis in the bone marrow and lymphoid atrophy in splenic tissues were compatible with laboratory findings of leukopenia, lymphopenia, and thrombocytopenia. Hypoxic and fatty changes of kidney and liver tissues are compatible with impaired renal or liver function.
CONCLUSIONS: Fatal A(H7N9) infection was characterized by viral and secondary bacterial pneumonia with 67% having positive RT-PCR in stool.

Entities:  

Keywords:  H7N9; avian; clinical; histopathology; influenza

Mesh:

Substances:

Year:  2013        PMID: 23943822     DOI: 10.1093/cid/cit541

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  62 in total

1.  Amino acid substitutions in polymerase basic protein 2 gene contribute to the pathogenicity of the novel A/H7N9 influenza virus in mammalian hosts.

Authors:  Chris Ka Pun Mok; Horace Hok Yeung Lee; Maxime Lestra; John Malcolm Nicholls; Michael Chi Wai Chan; Sin Fun Sia; Huachen Zhu; Leo Lit Man Poon; Yi Guan; Joseph Sriyal Malik Peiris
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

Review 2.  Pandemic potential of avian influenza A (H7N9) viruses.

Authors:  Tokiko Watanabe; Shinji Watanabe; Eileen A Maher; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Trends Microbiol       Date:  2014-09-25       Impact factor: 17.079

3.  Genesis and Spread of Newly Emerged Highly Pathogenic H7N9 Avian Viruses in Mainland China.

Authors:  Lei Yang; Wenfei Zhu; Xiyan Li; Minmei Chen; Jie Wu; Pengbo Yu; Shunxiang Qi; Yiwei Huang; Weixian Shi; Jie Dong; Xiang Zhao; Weijuan Huang; Zi Li; Xiaoxu Zeng; Hong Bo; Tao Chen; Wenbing Chen; Jia Liu; Ye Zhang; Zhenli Liang; Wei Shi; Yuelong Shu; Dayan Wang
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

4.  H7N9 influenza split vaccine with SWE oil-in-water adjuvant greatly enhances cross-reactive humoral immunity and protection against severe pneumonia in ferrets.

Authors:  Jørgen de Jonge; Harry van Dijken; Femke de Heij; Sanne Spijkers; Justin Mouthaan; Rineke de Jong; Paul Roholl; Eduardo Alfredo Adami; Milena Apetito Akamatsu; Paulo Lee Ho; Livia Brunner; Nicolas Collin; Martin Friede; José A Ferreira; Willem Luytjes
Journal:  NPJ Vaccines       Date:  2020-05-11       Impact factor: 7.344

5.  Assessment of antigen and molecular tests with serial specimens from a patient with influenza A(H7N9) infection.

Authors:  Kwok-Hung Chan; Kelvin K W To; Jasper F W Chan; Clara P Y Li; Kit-Man Chan; Honglin Chen; Pak-Leung Ho; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2014-03-26       Impact factor: 5.948

6.  Fatty Acid Metabolism is Associated With Disease Severity After H7N9 Infection.

Authors:  Xin Sun; Lijia Song; Shuang Feng; Li Li; Hongzhi Yu; Qiaoxing Wang; Xing Wang; Zhili Hou; Xue Li; Yu Li; Qiuyang Zhang; Kuan Li; Chao Cui; Junping Wu; Zhonghua Qin; Qi Wu; Huaiyong Chen
Journal:  EBioMedicine       Date:  2018-06-23       Impact factor: 8.143

7.  Ventilator management for acute respiratory distress syndrome associated with avian influenza A (H7N9) virus infection: A case series.

Authors:  Hui Xie; Zhi-Gang Zhou; Wei Jin; Cheng-Bin Yuan; Jiang Du; Jian Lu; Rui-Lan Wang
Journal:  World J Emerg Med       Date:  2018

Review 8.  Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease.

Authors:  Jasper F W Chan; Susanna K P Lau; Kelvin K W To; Vincent C C Cheng; Patrick C Y Woo; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

9.  Influenza A Virus Reassortment Is Limited by Anatomical Compartmentalization following Coinfection via Distinct Routes.

Authors:  Mathilde Richard; Sander Herfst; Hui Tao; Nathan T Jacobs; Anice C Lowen
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

10.  A host-based RT-PCR gene expression signature to identify acute respiratory viral infection.

Authors:  Aimee K Zaas; Thomas Burke; Minhua Chen; Micah McClain; Bradly Nicholson; Timothy Veldman; Ephraim L Tsalik; Vance Fowler; Emanuel P Rivers; Ronny Otero; Stephen F Kingsmore; Deepak Voora; Joseph Lucas; Alfred O Hero; Lawrence Carin; Christopher W Woods; Geoffrey S Ginsburg
Journal:  Sci Transl Med       Date:  2013-09-18       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.